REGENXBIO, Inc. (RGNX)
9.04
+0.24
(+2.73%)
USD |
NASDAQ |
Apr 13, 16:00
9.03
-0.01
(-0.11%)
After-Hours: 20:00
REGENXBIO Cash from Investing (TTM) : -15.87M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 69.64M |
| AbbVie, Inc. | -6.643B |
| Replimune Group, Inc. | 216.64M |
| Ocugen, Inc. | -0.311M |
| Krystal Biotech, Inc. | -58.42M |